Kezar Life Sciences, Inc. · NASDAQ:KZR
Fowler John Franklin reported 3 trades in Kezar Life Sciences, Inc. shares (Form 4)
Traded May 11, 2026 · Filed May 11, 2026
On May 11, 2026, Fowler John Franklin (Director) reported 3 trades in Kezar Life Sciences, Inc. shares, leaving 0 shares. Filed May 11, 2026 (Form 4).
- Shares
- 43,611 shares
- Holding after
- 0 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Other | 39,390 | 0 | Direct | |
| May 11, 2026 | Common Stock | Other | 375 | 0 | Indirect | |
| May 11, 2026 | Common Stock | Other | 3,846 | 0 | Indirect |
Source
Related
- Kezar Life Sciences, Inc.
- Fowler John Franklin
- Kezar Life Sciences, Inc. shareholders
- Schedule 13G/A · Baselake Partners, LP · May 28, 2026
- Schedule 13D/A · Tang Capital Management LLC · May 13, 2026
- Schedule 13G/A · Baselake Partners, LP · May 12, 2026
- Form 4 · Schiller Mark C. · May 11, 2026
- Form 4 · Kirk Christopher J. · May 11, 2026